NCAIDS, NCSTD, China CDC. Update on the AIDS/STD epidemic
in China the third quarter of 2018. Chin J AIDS STD 2018;
24(11): 1075. [in Chinese].
Shao Y. HIV resistance monitoring strategy and detection technology
(in Chinese): People’s medical publishing house 2010.
Nimitsantiwong P, Wathitphan C, Kaveepatharanon S, Thanomphakorn K, Chantratita W, Pasomsub E. Comparison of SENTOSA® SQ deep sequencing-based HIV-1 genotyping coupled to integrated workflow with sanger sequencing method for detection of drug resistance mutations. Southeast Asian J Trop Med Public Health 2018; 49(2): 10.
Herms J, Rodriguez C, Casadella M, et al. PASeq.org: One-click, Cloud-based web service for NGS-based HIV genotyping data analysis. Conference on Retroviruses and Opportunistic Infections. Boston, Massachusetts. 2018.
Levene MJ, Korlach J, Turner SW, Foquet M, Craighead HG, Webb WW. Zero-mode waveguides for single-molecule analysis at high concentrations. Science 2003; 299(5607): 682-6.
Ita S, Ben Murrell GC, Ignacio C, et al. SMRT sequencing of full-length pol amplicons to investigate hiv-1 drug resistance. Conference on Retroviruses and Opportunistic Infections. San Diego, CA USA. 2018.
Chinese CDC. National guideline for detection of HIV/AIDS (2015 edition). (in Chinese) Zhongguo Bingdubing Zazhi 2016; 6(6): 401-27.
Wang ZH, Zhang CY, Yan PP. Analysis on risk factors of drug resistance of HIV cases received antiretroviral therapy in Fujian, China. (in Chinese) Strait J Prev Med 2018; 24(5): 10-2.
Wang XL, Zeng H, Xu X. Drug resistance in HIV-infected persons receiving HIV antiviral therapy from 2010 to 2015. (in Chinese) Parasitoses and Infectious Diseases 2018; 16(2): 69-75.
Wang FY, Jin T, Ni MJ. Drug resistance analysis of AIDS patients in Yili Prefecture, Xinjiang. (in Chinese) Chin J Health Lab Tec 2018; 28(14): 1693-395.
Wang FY, Jin T, Ni MJ. Drug resistance of 1816 viral suppression failure cases of HIV treatment, Xinjiang. (in Chinese) Mod Prev Med 2018; 45(13): 2447-50.
Liu JF, Yang BH, Zhang M, et al. Drug resistance of initial antiviral therapy including LPV/r failed for HIV/AIDS patients. (in Chinese) Mod Prev Med 2018; 45(11): 2073-9.
Liu J, Yan JZ, Wang Z. The study of HIV-1 drug resistance transmission among newly reported HIV infections in Henan 2015. (in Chinese) Henan Med Res 2018; 27(4): 598-601.
Liang S, Yang H, Yuan D. Efficacy of extended treatment and influencing factors of HIV drug resistance patients in Sichuan. (in Chinese) J Prev Med Inf 2018; 34(7): 898-907.
Zhu XY, Wang GY, Kang DM. Analysis of drug resistance among HIV/AIDS receiving antiretroviral treatment in Shandong province. (in Chinese) Chin J AIDS STD 2017; 23(2): 107-11.
Zhou Y, Lu J. Risk factors associated with HIV drug resistance among ART virological failure patients taking first-line antiviral treatment from Jiangsu Province. (in Chinese) Chin J Dis Control Prev 2017; 21(12): 1191-4.
Liu Y, Gong FH, Yuan D. HIV antiretroviral treatment effect and drug resistance analysis in Chengdu in 2014. (in Chinese) J Prev Med Inf 2017; 33(12): 1296-300.
Liu JF, Li JJ, Zhu BS. Study on drug-resistant gene mutation of HIV-1 virulent strains in Wenshan Prefecture of Yunnan Province during 2014-2015. (in Chinese) Int J Lab Med 2017; 38(3): 307-10.
Li HQ, Lao YF. Effect of LPV/r based second-line ART after failure of the first-line ART in Yunnan province. (in Chinese) Chin J AIDS STD 2017; 23(9): 780-3.
Gai J, Wu J, Kang LY. Observation of HIV primary drug resistance effect of highly active antiretroviral therapy in Shanghai. (in Chinese) Dis Surveill 2017; 32(2): 162-7.
Yuan D, Ye L, Liu HL. Influencing factors for therapeutic effect and drug resistance among HIV/aids patients receiving antiviral therapy in some areas of Sichuan, 2014. (in Chinese) Mod Prev Med 2016; 43(13): 2445-52.
Wang HJ, Zhang FC, Zhou CY, Liu CY, Zhang LN. Analysis of drug resistance of antiviral treatment in patients with AIDS and study on treatment strategy. (in Chinese) China Modern Medicine 2016; 23(21): 33-6.
Luo DW, Wang SD, Xu X. Analysis on drug resistance and subtype of HIV-1 patients receiving antiretroviral treatment in Dazhou City, Sichuan Province. (in Chinese) J Prev Med Inf 2016; 32(1): 39-45.
Yang CB, Yang W, Zhu ZD. Analysis on the detection status of the HIV-1 resistant gene in Butuo county Liangshan prefecture of Sichuan province. (in Chinese) Mod Prev Med 2015; 42(16): 2983-5.
Li CX, Bai JS, Huang Y. Analysis of drug-resistance in HIV patients treated with antivirus-therapy in Kunming. (in Chinese) J Dermatology and Venereology 2014; 36(3): 137-9.
Zhao DC, Ma Y, Wang N. Drug resistance among HIV-infected adults receiving long term first-line antiretroviral treatment in China. (in Chinese) Chin J Exp Clin Infect Dis 2013; 7(2): 204-9.
Yu XH, Wu ZL, Yang DZ, Zhang YH, Guan GY. Study on the resistance of antiviral treatment for the HIV-1 patients in Ningxia. (in Chinese) Ningxia Med J 2013; 35(7): 623-4.
Yu GL, Qin B, Lin P. Investigation of HIV-1 drug resistance prevalence in AIDS patients with long-term HAART therapy in Guangdong Province. (in Chinese) J Newat Med 2013; 44(7): 463-6.
E S. Wu SH, Yao WQ. Distribution of HIV-1 subtypes and drug resistance analysis in the population of antiviral treatment in Liaoning Province from 2004 to 2011. (in Chinese) Chin J AIDS STD 2013; 19(8): 606-7.
Yao ST, Ma YL, Duan S. Mutation rate and risk factors of HIV resistance among AIDS patients receiving antiretroviral treatment in Dehong Prefecture, Yunnan Province. (in Chinese) Chin J Dis Control Prev 2012; 16(12): 1019-23.
Liao LJ, Zhong P. Evaluation of proficiency of HIV-1 drug resistance genotyping testing in three consecutive years in China. (in Chinese) Chin J AIDS STD 2012; 18(4): 206-9.
Ye F, Wu HW. Clinical molecular pathology laboratory second-generation gene sequencing detection expert consensus. (in Chinese) Chin J Pathol 2017; 46(3): 145-8.